Intravitreal injection of autologous bone marrow stem cells ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
90Retinitis pigmentosa3

90. Retinitis pigmentosa


Clinical trials : 147 Drugs : 176 - (DrugBank : 43) / Drug target genes : 49 - Drug target pathways : 110
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02280135
(ClinicalTrials.gov)
November 201422/10/2014Clinical Trial of Intravitreal Injection of Autologous Bone Marrow Stem Cells in Patients With Retinitis PigmentosaPhase I Clinical Trial of Intravitreal Injection of Autologous Bone Marrow Stem Cells in Patients With Retinitis PigmentosaRetinitis PigmentosaBiological: Intravitreal injection of Autologous bone marrow Stem Cell;Other: Subconjunctival injection of salineRed de Terapia CelularSpanish National Health System;Hospital Universitario Virgen de la Arrixaca;Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia;Public Health Service, Murcia;Instituto Murciano de Investigación Biosanitaria Virgen de la ArrixacaCompleted18 Years70 YearsAll8Phase 1Spain
2NCT01560715
(ClinicalTrials.gov)
June 201119/3/2012Autologous Bone Marrow-Derived Stem Cells Transplantation For Retinitis PigmentosaPhase 2 Study Of Autologous Bone Marrow-Derived Stem Cells Transplantation For Retinitis PigmentosaRetinitis PigmentosaBiological: intravitreal injection of autologous bone marrow stem cellsUniversity of Sao PauloNULLCompleted18 Years75 YearsAll50Phase 2Brazil
3NCT01068561
(ClinicalTrials.gov)
May 200910/2/2010Autologous Bone Marrow-Derived Stem Cells Transplantation For Retinitis PigmentosaPhase 1 Study Of Autologous Bone Marrow-Derived Stem Cells Transplantation For Retinitis PigmentosaRetinitis PigmentosaBiological: intravitreal injection of autologous bone marrow stem cellsUniversity of Sao PauloNULLCompleted18 YearsN/ABoth5Phase 1Brazil